Clinical Trial Update: Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intravenous Bendavia for reperfusion injury during renal artery angioplasty; the study was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension Renovascular
• Ischemia-reperfusion Injury
• Renal Artery Obstruction

Drugs mentioned

• Bendavia (MTP-131)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Renal Artery Obstruction, Hypertension, Renovascular | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-08-11